Fulgent Genetics (FLGT) Prices 4.2M Common Stock IPO at $9/Share, at Low-End of Expected Range

September 29, 2016 6:06 AM EDT
Get Alerts FLGT Hot Sheet
Trade FLGT Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Fulgent Genetics (Nasdaq: FLGT) announced the pricing of its initial public offering of 4,200,000 shares of its common stock at a public offering price of $9.00 per share, before underwriting discounts and commissions. Fulgent Genetics has granted the underwriters a 30-day option to purchase up to an additional 630,000 shares from the company at the same price. The shares are expected to begin trading on The NASDAQ Global Market on September 29, 2016, under the ticker symbol “FLGT.” The offering is expected to close on October 4, 2016, subject to customary closing conditions.

NOTE: The company was recently looking at a pricing range of $9 -$11 per share.

Credit Suisse Securities (USA) LLC and Piper Jaffray & Co. are serving as joint book-running managers for the offering. Raymond James & Associates, Inc. is serving as lead manager and BTIG, LLC is serving as co-manager.

A registration statement relating to the securities being sold in the offering was declared effective by the Securities and Exchange Commission on September 28, 2016. The offering is being made solely by means of a prospectus. When available, copies of the final prospectus relating to this offering may be obtained from Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, Eleven Madison Avenue, New York, NY 10010, by telephone at +1-800-221-1037, or by email at newyork.prospectus@credit-suisse.com; or from Piper Jaffray & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Suite 800, Minneapolis, MN 55402, by telephone at +1-800-747-3924, or by email at prospectus@pjc.com.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, IPOs

Related Entities

Credit Suisse, Piper Jaffray, Raymond James, IPO, BTIG

Add Your Comment